α-Mangostin enhances betulinic acid cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells

Molecules

Volumn 17, Issue 3, 2012, Pages 2939-2954

  Aisha, Abdalrahim F A ^a   Abu Salah, Khalid M ^b   Ismail, Zhari ^a   Majid, Amin Malik Shah Abdul ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Mangostin; Apoptosis; Betulinic acid; Cisplatin; Cytoprotection effects; Cytotoxicity enhancement

Indexed keywords

ANTINEOPLASTIC AGENT; BETULIC ACID; CASP3 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASPASE 3; CASPASE 7; CISPLATIN; MANGOSTIN; TRITERPENE; XANTHONE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SHAPE; CELL STRAIN HCT116; CELL SURVIVAL; CHROMATIN; COLORECTAL TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IC 50; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CHROMATIN; CISPLATIN; COLORECTAL NEOPLASMS; CYTOPROTECTION; DRUG SYNERGISM; HCT116 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; SIGNAL TRANSDUCTION; TRITERPENES; XANTHONES;

EID: 84858980716     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17032939     Document Type: Article

References (42)

1. International Agency for Research on Cancer. All Cancers (excluding non-melanoma skin cancer) Incidence and Mortality Worldwide in 2008. In Globocan 2008; IARC: Lyon, France, 2010.
2. Cercek, A.; Saltz, L. B. First-line treatment of patients with metastatic colorectal cancer: An overview of recent data on chemotherapy plus targeted agents. Clin. Colorectal Cancer 2008, 7(Suppl 2), S47-S51.
3. Obolskiy, D.; Pischel, I.; Siriwatanametanon, N.; Heinrich, M. Garcinia mangostana L.: A phytochemical and pharmacological review. Phytother. Res. 2009, 23, 1047-1065.
4. Matsumoto, K.; Akao, Y.; Kobayashi, E.; Ohguchi, K.; Ito, T.; Tanaka, T.; Iinuma, M.; Nozawa, Y. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J. Nat. Prod. 2003, 66, 1124-1127. (Pubitemid 37034054)
5. Matsumoto, K.; Akao, Y.; Yi, H.; Ohguchi, K.; Ito, T.; Tanaka, T.; Kobayashi, E.; Iinuma, M.; Nozawa, Y. Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg. Med. Chem. 2004, 12, 5799-5806. (Pubitemid 39388179)
6. Fulda, S. Betulinic acid for cancer treatment and prevention. Int. J. Mol. Sci. 2008, 9, 1096-1107. (Pubitemid 351948841)
7. Mukherjee, R.; Jaggi, M.; Rajendran, P.; Siddiqui, M. J. A.; Srivastava, S. K.; Vardhan, A.; Burman, A. C. Betulinic acid and its derivatives as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 2004, 14, 2181-2184. (Pubitemid 38481386)
8. Leong, H.; Mathur, P. S.; Greene, G. L. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation. Breast Cancer Res. Treat. 2009, 117, 505-515.
9. Chung, Y. C.; Lin, C. C.; Chou, C. C.; Hsu, C. P. The effect of Longan seed polyphenols on colorectal carcinoma cells. Eur. J. Clin. Invest. 2010, 40, 713-721.
10. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995, 49, 57-68. (Pubitemid 26010740)
11. Recio, M. C.; Giner, R. M.; Manez, S.; Gueho, J.; Julien, H. R.; Hostettmann, K.; Rios, J. L. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med. 1995, 61, 9-12.
12. Chintharlapalli, S.; Papineni, S.; Ramaiah, S. K.; Safe, S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007, 67, 2816-2823. (Pubitemid 46548971)
13. Chintharlapalli, S.; Papineni, S.; Lei, P.; Pathi, S.; Safe, S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 2011, 11, doi:10.1186/1471-2407-11-371.
14. Jung, G. R.; Kim, K. J.; Choi, C. H.; Lee, T. B.; Han, S. I.; Han, H. K.; Lim, S. C. Effect of betulinic acid on anticancer drug-resistant colon cancer cells. Basic Clin. Pharmacol. Toxicol. 2007, 101, 277-285. (Pubitemid 350194804)
15. Fulda, S.; Kroemer, G. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov. Today 2009, 14, 885-890.
16. Siddik, Z. H. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22, 7265-7279. (Pubitemid 37487159)
17. Boulikas, T.; Vougiouka, M. Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 2003, 10, 1663-1682.
18. Tsuchida, R.; Das, B.; Yeger, H.; Koren, G.; Shibuya, M.; Thorner, P.; Baruchel, S.; Malkin, D. Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling. Oncogene 2008, 27, 3923-3934. (Pubitemid 351913641)
19. Späth-Schwalbe, E.; Lange, C.; Genvresse, I.; Krüger, L.; Eucker, J.; Schweigert, M.; Sezer, O.; Budach, V.; Possinger, K. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma-a phase II study. Anticancer Drugs 2002, 13, 395.
20. Ozben, T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 2006, 580, 2903-2909. (Pubitemid 43729172)
21. Mayer, L. D.; Shabbits, J. A. The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance. Cancer Metastasis Rev. 2001, 20, 87-93. (Pubitemid 34074683)
22. Jabr-Milane, L. S.; van Vlerken, L. E.; Yadav, S.; Amiji, M. M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 2008, 34, 592-602.
23. Petit, J. M.; Denis-Gay, M.; Ratinaud, M. H. Assessment of fluorochromes for cellular structure and function studies by flow cytometry. Biol. Cell 1993, 78, 1-13. (Pubitemid 23278742)
24. Sensi, S. L.; Ton-That, D.; Sullivan, P. G.; Jonas, E. A.; Gee, K. R.; Kaczmarek, L. K.; Weiss, J. H. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc. Natl. Acad. Sci. USA 2003, 100, 6157-6162. (Pubitemid 36576947)
25. Darzynkiewicz, Z.; Traganos, F.; Staiano-Coico, L.; Kapuscinski, J.; Melamed, M. Interactions of rhodamine 123 with living cells studied by flow cytometry. Cancer Res. 1982, 42, 799-806. (Pubitemid 12141175)
26. Fulda, S.; Debatin, K. M. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol. 2000, 35, 616-618.
27. Rajput, A.; Dominguez San Martin, I.; Rose, R.; Beko, A.; Levea, C.; Sharratt, E.; Mazurchuk, R.; Hoffman, R. M.; Brattain, M. G.; Wang, J. Characterization of HCT116 human colon cancer cells in an orthotopic model. J. Surg. Res. 2008, 147, 276-281. (Pubitemid 351680466)
28. Huang, H. L.; Fang, L. W.; Lu, S. P.; Chou, C. K.; Luh, T. Y.; Lai, M. Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003, 22, 8168-8177.
29. Pedraza-Chaverri, J.; Reyes-Fermin, L. M.; Nolasco-Amaya, E. G.; Orozco-Ibarra, M.; Medina-Campos, O. N.; Gonzalez-Cuahutencos, O.; Rivero-Cruz, I.; Mata, R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp. Toxicol. Pathol. 2009, 61, 491-501.
30. Sánchez-Pérez, Y.; Morales-Bárcenas, R.; García-Cuellar, C. M.; López-Marure, R.; Calderon-Oliver, M.; Pedraza-Chaverri, J.; Chirino, Y. I. The [alpha]-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction. Chem. Biol. Interact. 2010, 188, 144-150.
31. Yoon, J. J.; Lee, Y. J.; Kim, J. S.; Kang, D. G.; Lee, H. S. Protective role of betulinic acid on TNF-[alpha]-induced cell adhesion molecules in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2010, 391, 96-101.
32. Szuster-Ciesielska, A.; Pilipów, K.; Kandefer-Szersze, M. Protective effect of betulin and betulinic acid on acetaminophen and ethanol-induced cytotoxicity and reactive oxygen species production in HepG2 cells. J. Pre-Clin. Clin. Res. 2010, 4, 96-100.
33. Karna, E.; Szoka, L.; Palka, J. A. Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol. Cell. Biochem. 2010, 340, 15-20.
34. Rzeski, W.; Stepulak, A.; Szymanski, M.; Sifringer, M.; Kaczor, J.; Wejksza, K.; Zdzisinska, B.; Kandefer-Szerszen, M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch. Pharmacol. 2006, 374, 11-20.
35. Wu, Q.; He, J.; Fang, J.; Hong, M. Antitumor effect of betulinic acid on human acute leukemia K562 cells in vitro. J. Huazhong Univ. Sci. Technol. Med. Sci. 2010, 30, 453-457.
36. Aisha, A. F. A.; Abu-Salah, K. M.; Alrokayan, S. A.; Siddiqui, M. J.; Ismail, Z.; Abdul Majid, A. M. S. Syzygium aromaticum extracts as good source of betulinic acid and potential anti-breast cancer. Rev. Bras. Farmacogn. 2011, doi:10.1590/S0102-695X2011005000185.
37. Jost, L. M.; Kirkwood, J. M.; Whiteside, T. L. Improved short-and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J. Immunol. Methods 1992, 147, 153-165.
38. Aisha, A. F. A.; Sahib, H. B.; Abu-Salah, K. M.; Darwis, Y.; Abdul Majid, A. M. S. Cytotoxic and anti-angiogenic properties of the stem bark extract of Sandoricum koetjape. Int. J. Cancer Res. 2009, 5, 105-114.
39. Aisha, A. F. A.; Abu-Salah, K. M.; Nassar, Z. D.; Siddiqui, M. J.; Ismail, Z.; Abdul Majid, A. M. S. Antitumorigenicity of xanthones-rich extract from Garcinia mangostana fruit rinds on HCT 116 human colorectal carcinoma cells. Rev. Bras. Farmacogn. 2011, 21, 1025-1034.
40. Johnson, L. V.; Walsh, M. L.; Chen, L. B. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. USA 1980, 77, 990-994. (Pubitemid 10105043)
41. Kanwar, S. S.; Yu, Y.; Nautiyal, J.; Patel, B. B.; Majumdar, A. P. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol. Cancer 2010, 9, doi:10.1186/1476-4598-9-212.
42. Webb, J. Effect of More Than One Inhibitor, in Enzyme and Metabolic Inhibitors; Academic Press: New York, NY, USA, 1963; Volume 1, p. 72.